Sunrun heads into the back half of the week with a punishing earnings-day drop still fresh, a heavily shorted position that barely budged, and a wave of analyst target cuts landing in the hours after the print.
The earnings reaction tells the story bluntly. Sunrun reported Q2 results on August 5, and the stock fell almost 15% that day. The bounce since — up roughly 9% on August 7 alone — claws back only part of that damage. On a one-month view the stock is still down 16% to $10.20, and the rebound looks more like a relief trade than a rerating. The Q2 cash generation miss was the headline problem: $27 million delivered against $50–$60 million guided, a shortfall that undermined management's bullish story around net value creation, even as the company raised its full-year guidance range to $1.0–$1.3 billion.
Short positioning reflects a market that was already skeptical and remains so. Short interest holds at 28.7% of free float — roughly 66.6 million shares — barely changed across the week despite the earnings volatility. The month-long trend shows a sharper picture: short interest has grown about 12% over the past 30 days, with the bulk of that build concentrated between early July and mid-July, when short positions jumped from roughly 59 million shares to 67 million. Borrowing costs remain remarkably cheap at 0.48%, suggesting the short side faces no meaningful funding pressure. Availability is comfortable at 371% of short interest — well into normal territory — meaning there is no mechanical squeeze threat from tightening supply. The ORTEX short score, at 64.5, has drifted lower from 66.3 three weeks ago, which reflects the slight easing in some pressure metrics but remains elevated.
Options traders, by contrast, have turned notably bullish in the near term. The put/call ratio has dropped to 0.32 — its lowest reading of the past 52 weeks and well below its 20-day average of 0.34. That z-score of -1.4 signals call-side demand outpacing puts by a meaningful margin, consistent with traders positioning for a bounce after the earnings selloff. The contrast between a PCR near a 52-week low and a short interest near 52-week highs is the clearest tension in the setup right now: options flow says bounce, structural short positioning says the skeptics haven't left.
The Street kept ratings intact but moved targets sharply lower. Goldman Sachs, Citigroup, TD Cowen, RBC Capital, and Susquehanna all maintained positive ratings in the two days after earnings while cutting targets — Goldman to $15 from $18, TD Cowen to $16 from $21, RBC to $14 from $18. At $10.20, even the newly reduced targets imply 40–60% upside, which explains why no one pulled a Buy. The lone bear on record, GLJ Research, maintains a Sell with a $4.63 target, a reading far below the pack that reflects a structurally different view on the business model. Factor scores add nuance: 90-day EPS momentum ranks in the 99th percentile — a genuine positive — but EPS surprise scores near the bottom at the 1st percentile, and the short score rank sits in just the 6th percentile, marking Sunrun as one of the more heavily shorted names in the universe by that measure.
Insider activity adds a cautionary note. The 90-day net flow is a net sell of roughly $3 million in value. Founder Lynn Jurich sold 50,000 shares on August 3 at $9.96, adding to a 50,000-share sale at $13.61 on July 1. CEO Mary Powell, CFO Danny Abajian, and President Paul Dickson all sold modest amounts on July 6 at prices around $13.19 — well above where the stock sits now. These were small in absolute dollar terms, but the pattern of selling from the CEO, CFO, President, and Founder across the same period is worth noting against the bullish guidance revision.
The next scheduled earnings date is November 4. Between now and then, the key variable is whether cash generation in Q3 begins to close the gap with management's full-year target — the guidance revision only holds if the Q2 shortfall proves idiosyncratic rather than structural.
See the live data behind this article on ORTEX.
Open RUN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
